Tag: Monash Institute of Pharmaceutical Sciences
Seaport Therapeutics secures $100M to harness Monash invention
Seaport Therapeutics, a biopharmaceutical company in the clinical stage, centred on an innovative drug delivery system initially created by researchers from Monash University, announced the completion of a Series A funding round, which raised USD 100 million (AUD 154 million).
Moderna launches new mRNA Platform Incubator Network in Australia
US biotech giant Moderna is establishing an mRNA Platform Incubator Network in Australia to advance the nation’s mRNA medicine and scientific excellence in clinical translation.
Moderna establishes mRNA Regional Research Centre, HQ in Melbourne
Biotechnology giant Moderna is opening a Regional Research Centre and Headquarters in Melbourne, boosting advancements in the local mRNA industry in Victoria.
Monash University teams up with Moderna to support locally made mRNA innovations
Monash University and Moderna have partnered to establish the Monash-Moderna Quantitative Pharmacology Accelerator (MMQPA), a program aimed at fostering local innovations in mRNA medicines, including therapeutics and vaccines.
Victoria spearheads world-first mRNA research collaboration with new innovation hub
The Victorian government is continuing its commitment to boosting mRNA in a new collaboration with the state’s biggest research institutions, a first-of-its-kind partnership in...
IDT announces successful manufacture of Australia’s first mRNA COVID-19 vaccine candidate
It took just five months for Victorian scientists and manufacturers to develop Australia's first mRNA COVID-19 vaccine candidate — the country's first ever mRNA medicinal product – allowing...
IDT Australia ready to begin small-scale manufacturing of Australia’s first mRNA vaccine in preparation...
Boronia-based company IDT Australia is set to take delivery of a key piece of equipment that will enable the critical manufacturing capability of mRNA...
IDT in talks to manufacture Australia’s first COVID-19 vaccine candidate
Melbourne-based pharmaceutical manufacturer IDT Australia is locked in discussions with the Victorian Government, mRNA Victoria and the Monash Institute of Pharmaceutical Sciences (MIPS) to...
Monash awarded $5m grant to manufacture Australia’s first COVID-19 vaccine candidate
The Monash Institute of Pharmaceutical Sciences (MIPS) has received $5 million from the Victorian Government to manufacture doses of Australia’s first COVID-19 vaccine candidate...
Victorian scientist from Monash Institute recognised for advances in fighting African sleeping disease
Lori Ferrins from Templestowe, Victoria has won this year’s BASF Science and Technology Award at the Victorian Young Achiever Awards at Etihad Stadium for...
Featured Article
The future of sports manufacturing: Inside M2M Group’s AI-powered strategy
As the sports manufacturing industry evolves, artificial intelligence (AI) is emerging as a critical catalyst for innovation and efficiency.
